Search - tctmd.com

Displaying 1 - 20 of 39

Sort: Relevancy | Date

News Daily News

JACC Debuts Data Digest on CV Health in the United States

Caitlin E. Cox

January 12, 2026

News Daily News

COVID-19 Increases MACE Risk Nearly 3 Years Later: UK Biobank

Todd Neale

October 10, 2024

News Daily News

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

Michael O'Riordan

July 25, 2023

News Daily News

Interventional Cardiology Training Needs Defined for the First Time

Yael L. Maxwell

February 20, 2023

News Daily News

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

Michael O'Riordan

November 18, 2022

News Daily News

NSTEMI Patients With CKD: Early Invasive vs Delayed Strategy Similar for Survival

Caitlin E. Cox

October 03, 2022

News Daily News

Good News and Bad for High-Intensity Statin Use in ASCVD

Michael O'Riordan

May 05, 2022

News Daily News

Don’t Rule Out CABG for Elderly Patients With Multiple Comorbidities

Michael O'Riordan

April 25, 2022

News Daily News

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

Michael O'Riordan

March 30, 2022

News Daily News

PAD Significantly Ups Morbidity and Mortality in AMICS

L.A. McKeown

March 29, 2022

News Daily News

Before and After PCI, Women Have Poorer Health Status Than Men

L.A. McKeown

January 28, 2022

News Daily News

Discharge Safe as Early as a Day After Primary PCI for STEMI

L.A. McKeown

December 15, 2021

News Daily News

Age Not the Only Explanation for Sex Gap in PCI Care, Outcomes

Caitlin E. Cox

November 03, 2021

News Daily News

OMT Boosts Survival in Revascularized Patients at 10 Years

Michael O'Riordan

June 29, 2021

News Daily News

In Female Veterans With Early ASCVD, Secondary Prevention Falls Short

Michael O'Riordan

April 21, 2021

News Daily News

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Michael O'Riordan

October 28, 2020

News Daily News

Registry Supports Paclitaxel DCBs in CLI Patients to 2 Years

L.A. McKeown

September 17, 2020

News Daily News

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Michael O'Riordan

August 06, 2020

News Daily News

Women More Likely Than Men to Develop Heart Failure After STEMI

L.A. McKeown

November 04, 2019

News Daily News

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

Michael O'Riordan

August 26, 2019

Advertisement

JACC Debuts Data Digest on CV Health in the United States

COVID-19 Increases MACE Risk Nearly 3 Years Later: UK Biobank

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

Interventional Cardiology Training Needs Defined for the First Time

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

NSTEMI Patients With CKD: Early Invasive vs Delayed Strategy Similar for Survival

Good News and Bad for High-Intensity Statin Use in ASCVD

Don’t Rule Out CABG for Elderly Patients With Multiple Comorbidities

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

PAD Significantly Ups Morbidity and Mortality in AMICS

Before and After PCI, Women Have Poorer Health Status Than Men

Discharge Safe as Early as a Day After Primary PCI for STEMI

Age Not the Only Explanation for Sex Gap in PCI Care, Outcomes

OMT Boosts Survival in Revascularized Patients at 10 Years

In Female Veterans With Early ASCVD, Secondary Prevention Falls Short

Failure to Access Coronaries After TAVR Almost Exclusive to CoreValve Evolut

Registry Supports Paclitaxel DCBs in CLI Patients to 2 Years

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Women More Likely Than Men to Develop Heart Failure After STEMI

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content